ad-hgf
Biologicalexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2012 (NCT01925352)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Hepatocyte growth factorINHIBITOR
HGF inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ad-hgf
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02844283 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2016 | Nanjing Medical University |
| NCT01925352 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2012 | Nanjing Medical University, People's Liberation Army of China |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Nanjing Medical University | Academic/Hospital | 2 | 2 | 1 | 2012 |
| People's Liberation Army of China | Government | 1 | 0 | 1 | 2012 |
2 organizations
Page 1 / 1